Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8

Liver gene transfer with adeno-associated viral (AAV) 2/8 vectors is being considered for therapy of systemic diseases like mucopolysaccharidosis type VI (MPS VI), a lysosomal storage disease due to deficiency of arylsulfatase B (ARSB). We have previously reported that liver gene transfer with AAV2/...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ferla, Rita, O'Malley, Thomas, Calcedo, Roberto, O'Donnell, Patricia, Wang, Ping, Cotugno, Gabriella, Claudiani, Pamela, Wilson, James M., Haskins, Mark, Auricchio, Alberto
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2013
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581049/
https://ncbi.nlm.nih.gov/pubmed/23194248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2012.179
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky